Physician profile
Pat D DO
NPI 1013994979
$7,213.55
in general payments reported to CMS, 2019-2025
20 companies · $55.63 in 2025
The $55.63 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $288 · 2020: $188 · 2021: $273 · 2022: $1,250 · 2023: $5,127 · 2024: $31.64 · 2025: $55.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $5,036 · Food and Beverage: $179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $5,035.67 |
| Food and Beverage | $178.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Djo, LLC | $5,035.67 | 2023 | |
| Titan Surgical Group, LLC | $1,200.00 | 2022 | |
| Smith+Nephew, INC. | $147.62 | 2021 | |
| Encore Medical, LP | $113.68 | 2021 | |
| Cerapedics INC. | $113.25 | 2020 | |
| Ferring Pharmaceuticals INC. | $105.37 | 2020-2025 | Euflexxa |
| Electronic Waveform Lab, INC. | $97.15 | 2019 | |
| Spinal Simplicity, LLC | $81.67 | 2019 | |
| Pacira Therapeutics, INC. | $76.30 | 2019-2021 | |
| Flower Orthopedics Coporation | $46.42 | 2023 | |
| Fidia Pharma USA INC. | $39.58 | 2019 | |
| Linvatec Corporation | $23.16 | 2025 | Conmed Handheld Instruments |
| Depuy Synthes Sales INC. | $20.26 | 2022 | |
| Amgen INC. | $18.40 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $18.31 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $17.37 | 2019 | |
| Heron Therapeutics, INC. | $17.10 | 2023 | Zynrelef |
| Bioventus LLC | $15.11 | 2022 | |
| Zyla Life Sciences, INC. | $14.82 | 2019 | |
| Allergan, INC. | $12.31 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pat DO listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.